Mucopolysaccharidosis Type I (MPS I) represents one of the most challenging genetic disorders, affecting approximately 1 in 100,000 births worldwide. This lysosomal storage disease occurs when the body lacks sufficient alpha-L-iduronidase enzyme, leading to the accumulation of glycosaminoglycans in various tissues and organs. While current treatments like enzyme replacement...